Abstract
The repair of musculoskeletal tissues has posed a constant challenge for orthopaedic surgeons, and the occurrence of bone and cartilage injuries is expected to increase with the aging of the world population. To overcome the limitations of current treatments, tissue engineering enhanced through gene therapy is garnering significant interest as a promising new alternative. This paper reviews the essential factors involved in tissue engineering, including the appropriate cell source, inductive agents, scaffolds, and mechanical stimulation. Particular emphasis is placed on the use of muscle-derived stem cells that can be genetically engineered to deliver growth factors to the site of injury and initiate the formation of new bone and cartilage. These same gene-carrying cells may also serve as a source of progenitor cells for bone and cartilage formation, making muscle-based gene therapy and tissue engineering a potential treatment for cartilage and bone defects.
Keywords: tissue engineering, gene therapy, mdsc, bone, cartilage, bmps
Current Genomics
Title: Muscle-Based Gene Therapy and Tissue Engineering for Cartilage and Bone Healing
Volume: 5 Issue: 1
Author(s): K. Corsi, G. H. Li, H. Peng and J. Huard
Affiliation:
Keywords: tissue engineering, gene therapy, mdsc, bone, cartilage, bmps
Abstract: The repair of musculoskeletal tissues has posed a constant challenge for orthopaedic surgeons, and the occurrence of bone and cartilage injuries is expected to increase with the aging of the world population. To overcome the limitations of current treatments, tissue engineering enhanced through gene therapy is garnering significant interest as a promising new alternative. This paper reviews the essential factors involved in tissue engineering, including the appropriate cell source, inductive agents, scaffolds, and mechanical stimulation. Particular emphasis is placed on the use of muscle-derived stem cells that can be genetically engineered to deliver growth factors to the site of injury and initiate the formation of new bone and cartilage. These same gene-carrying cells may also serve as a source of progenitor cells for bone and cartilage formation, making muscle-based gene therapy and tissue engineering a potential treatment for cartilage and bone defects.
Export Options
About this article
Cite this article as:
Corsi K., Li H. G., Peng H. and Huard J., Muscle-Based Gene Therapy and Tissue Engineering for Cartilage and Bone Healing, Current Genomics 2004; 5 (1) . https://dx.doi.org/10.2174/1389202043490005
DOI https://dx.doi.org/10.2174/1389202043490005 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anticancer Antifolates: Current Status and Future Directions
Current Pharmaceutical Design The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Current Medicinal Chemistry Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Diverse Roles of GADD45α in Stress Signaling
Current Protein & Peptide Science Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Anti-Cancer Agents in Medicinal Chemistry Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets Liquid Chromatographic Analysis of Methotrexate and Minocycline-relevance to the Determination in Plasma/Nanoparticulate Formulations
Current Chromatography The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Transcriptionomic Study on Apoptosis of SKOV-3 Cells Induced by Phycoerythrin from <i>Gracilaria lemaneiformis</i>
Anti-Cancer Agents in Medicinal Chemistry Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Concise Review; The Recent Methods that Enhance the Osteogenic Differentiation of Human Induced Pluripotent Stem Cells
Current Stem Cell Research & Therapy Characterizing the Relationship Between the Chemical Structures of Drugs and their Activities on Primary Cultures of Pediatric Solid Tumors
Current Medicinal Chemistry Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters Effect of Proteasome Inhibitors on the AAV-Mediated Transduction Efficiency in Retinal Bipolar Cells
Current Gene Therapy Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets